Davis, Posteraro, and Wasser, MDs, LLP

Manchester, Connecticut 06105

0 studies enrolling now · 5 studies all time

What they study most

Chronic Idiopathic Thrombocytopenic Purpura, Colonic Neoplasms, Colorectal Neoplasms, Idiopathic Thrombocytopenic Purpura, Immune Thrombocytopenic Purpura, Prostate Cancer, Purpura, Thrombocytopenic, Idiopathic, Rectal Neoplasms

Studies at this site

• Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation — Completed
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. — Completed
• Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003 — Completed
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) — Completed
• Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) — Stopped early